NEW YORK , Aug. 28, 2022 /PRNewswire/ -- Can Traditional Chinese Medicine (TCM) really help women suffering from gynecological issues?
Indeed, it can, several doctors said at the recent "2022 US-China Integrated Western and Chinese Medicine Symposium," that took over Zoom on August 25th , thanks to the Committee of Medical Collaboration of the Sino-American Friendship Association, (SAFA), and the US-China Center for TCM.
Distinguished doctors from China , including Dr. Minru Liu, the first women living legend of a TCM master; Dr. Songping Luo , Yale senior visiting scholar and a leading inheritor of Gynecology Master Yuankai Luo; Dr. Yigong Fang , Vice-Dean of China Academy of Chinese Medical Sciences Hospital of Acupuncture and Moxibustion, as well as US experts in the field, including Dr. Ting Bao, Director of Integrative Breast Oncology Program of Memorial Sloan Kettering Cancer Center and Dr. Tony Tsai , Director of New York Fertility Center, shared their knowledge with over 3,800 participants from the US and around the world.
All of the doctors shared new ideas on a coordinated integration of western and Chinese medicine. The Chinese doctors shared that integration of TCM and acupuncture, combined with Western medicine, can be helpful to women with fertility issues while the Western doctors agreed that a combination therapy could be beneficial.
Guolin Zhou , Counselor of the Chinese Consulate General in New York , noted that "the philosophy of the TCM has great impact, and enjoys a very bright future."
Li Li , co-chair of the Committee of Medical Collaboration of the Sino-American Friendship Association, added: "We are hopeful this event will help to enhance communication between medical professionals and strengthen the exchanges and collaborations between the U.S and China , so more people can benefit from it."
New York State Governor Kathleen Hochul , in her congratulatory letter noted that "the partnership among healthcare officials, doctors and professors, to discuss unique perspectives between western and Chinese medicines is important in exploring various treatment options."
New York Mayor Eric Adams and US Congresswoman Grace Meng also sent congratulatory letters.
View original content:https://www.prnewswire.com/news-releases/safa-top-medical-experts-offer-advice-on-traditional-chinese-medicine-treatment-for-female-disorders-301613508.html
Stéphane Bancel discusses the company’s latest Covid shot and prospects for using mRNA in seasonal flu vaccines and personalized treatments for cancer
Intellia said Friday it knocked out the gene responsible for a rare and deadly swelling disorder. But CRISPR stocks sank.
Investors have lost patience with the slow-paced clinical trials of genetic therapies, and some are using the upbeat news to exit Intellia and peers.
Omeros Corp (NASDAQ: OMER) reported results from the narsoplimab arm of the I-SPY COVID Trial, sponsored by Quantum Leap Healthcare Collaborative (QLHC). Narsoplimab showed the largest reduction in mortality risk to date across all drugs reported from the I-SPY COVID Trial. The company said that in approximately half of the patients died in the narsoplimab group, and narsoplimab was not given or was prematurely stopped, with those patients dying 9 to 35 days later. Omeros adds that despite narso
Regeneron (REGN) and its partner Alnylam announce promising data from its ongoing phase I study evaluating ALN-HSD in healthy adults and NASH patients.
Gilead Sciences Inc (NASDAQ: GILD) announced updates to the World Health Organization's (WHO) Therapeutics and COVID-19: living guideline, which now conditionally recommends Veklury (remdesivir) for severe COVID-19. WHO continues to conditionally recommend Veklury in those with non-severe COVID-19 at the highest risk of hospitalization. The WHO conditional recommendation is mainly driven by the final results of the WHO-sponsored SOLIDARITY study, which showed a statistically significant 17% lowe
A San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis, opening a new $41 million office within the Cortex innovation district. It says the new facility will be critical to advancing research to treat several infectious diseases, including Covid-19.
These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q4 2022.
In a recent interview with PEOPLE, the couple, whose real-life love story was portrayed in The Big Sick, opened up about what it's like to be in the immunocompromised community
J&J (JNJ) announces a new $5 billion stock buyback plan. CHMP recommends authorizing Pfizer's (PFE) Omicron BA.4 and BA.5 boosters in Europe.
Intellia Therapeutics said two of its experimental Crispr treatments produced positive results in early-stage trials.
The following two healthcare stocks look like great buys for investors seeking to collect both above-average income and increase wealth. The good news for cancer patients is that Merck's (NYSE: MRK) cancer drug called Keytruda is approved in the U.S. to treat 19 different forms of the disease. Looking out over the long term, Merck's pipeline is just as strong as its existing products.
Eloxx Pharmaceuticals' (ELOX) phase II combination study evaluating pipeline candidate ELX-02 in cystic fibrosis fails to achieve statistical significance in efficacy endpoints.
The latest clinical news from Bristol Myers Squibb (NYSE: BMY) was quite encouraging, sufficient to drive the pharmaceutical giant's stock higher on an otherwise uninspired day for the broader stock market. Bristol Myers Squibb's share price experienced a nearly 2% bump, a notably better showing than the S&P 500 index's more than 1% decline. Bristol Myers Squibb's good news from the lab was that its enduringly popular cancer drug Opdivo did quite well in its latest round of testing.
"If we are forcing millions of people into this world, we as a society — whether you are right, whether you are left, whether you are 'pro-life' or not — it doesn't matter. You will all suffer the consequences of a crowded, broken political, healthcare, and education system."View Entire Post ›
In June, a Dallas area doctor who was feeling unwell wanted to use a saline IV bag she had gotten from her work to try to rehydrate. She tapped it into her veins while at home. Minutes later, she suffered a major medical event and died, court records say. Now, Raynaldo Rivera Ortiz Jr., an anesthesiologist at her surgical facility, faces federal charges for allegedly tampering with IV bags in a way that resulted in the death of his colleague as well as several other cardiac emergencies, accordin
A labor shortage at a pharmaceutical company along with increased demand left Adderall on back-order at many pharmacies across the country.
The San Carlos company has 125 employees and is applying its pulsed electric field systems in lung cancer and, potentially, drug delivery.
On the one hand, Sen. Ron Johnson argues that Social Security and Medicare should not be guaranteed but rather "negotiated" by Congress each year, leaving seniors with no sense of how much they can expect to receive the following year. On the other hand, a group of eight Democratic senators recently introduced legislation that would expand Social Security benefits by $2,400 a year. Rubio proposes a paid parental leave program that would force parents to take money out of their future Social Security earnings.
Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?